Search

Search Constraints

You searched for: Author/Creator Hentschel, Bettina

Search Results

1. ACTR-64. OBJECTIVE RESPONSES TO CHEMOTHERAPY IN RECURRENT GLIOMA DO NOT PREDICT BETTER SURVIVAL: A PROSPECTIVE ANALYSIS FROM THE GERMAN GLIOMA NETWORK. (5th November 2018)

2. Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy. Issue 10 (19th November 2013)

3. BIOM-59. TERT PROMOTER MUTATION AND MGMT PROMOTER METHYLATION-MEDIATED SENSITIVITY TO TEMOZOLOMIDE IN IDH-WILDTYPE GLIOBLASTOMA: IS THERE A LINK?. (9th November 2020)

4. CBMT-12. FOCAD LOSS IMPACTS MICROTUBULE ASSEMBLY, G2/M PROGRESSION AND PATIENT SURVIVAL IN ASTROCYTIC GLIOMAS. (11th November 2019)

5. Chemotherapy for adult patients with spinal cord gliomas. Issue 4 (8th March 2021)

7. CSIG-27. DIFFERENTIAL ELEVATION OF TERT ACTIVITY AND SENSITIVITY TO TEMOZOLOMIDE BY TYPE OF TERT MUTATION IN MGMT PROMOTER-METHYLATED GLIOBLASTOMA. (5th November 2018)

8. Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild‐type glioblastoma. Issue 7 (4th April 2014)

9. Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma. (11th April 2017)

10. Molecular characterization of long‐term survivors of glioblastoma using genome‐ and transcriptome‐wide profiling. Issue 8 (28th March 2014)